Introduction
Talipariti elatus Sw. Fryxell (majagua) fam. Malvaceae is a wooden botanical species that is endemic to Jamaica and Cuba ( Figure 1 ). 1, 2 However, there is little information about the biological properties of this species. 3 Nonclinical studies have provided evidence on some biological activities of quercetin, rutin, and gossypitrin, the major flavonoids of T. elatus flowers. 4 For instance, quercetin and ruitn inhibited histamine release from mast cells, 5, 6 reduced phospholipase A2 activity and recruitment of neutrophils and eosinophils into the lung. 5 Furthermore, rutin is a known protector from capillary permeability by histamine and other compounds.
research strategy for the characterization of its therapeutic potential should include the evaluation of its possible inhibitory effect on the release of chemical mediators, the contraction of airways smooth muscle and the increase of vascular permeability stimulated by histamine and other inflammatory agents. Accordingly, this study was aimed to assess the presence of one of these biological properties in a hydro-alcohol extract of T. elatus flower petals; this is the ability to inhibit histamine-induced increase of capillary permeability. It is the first stage of a research project that deals with the pharmacological study of this endemic species.
Materials and Methods

Plant Material
Flowers were collected from T. elatus Sw. Fryxell trees planted in parterres at Cerro Municipality of Havana, in the morning during July and August 2015. The taxonomic identification of this botanic species was performed by the Central Laboratory of Pharmacology from Salvador Allende Faculty of Medicine, University of Medical Sciences of Havana, Cuba. Its identity was demonstrated by comparison with the sample registered at Havana Botanic Garden (Voucher number HAJB 82587). The flower petals were separated and cut into pieces, dried in an oven at 40ºC for 12 hours (Figure 2) , and reduced to small particles of about 3 mm by using a mesh battery.
Preparation of Plant Extract
An extract of T. elatus flower (TFE) petals was prepared by the method Miranda and Cuellar. 13 It was obtained by percolation of dried plant material with 70% ethanol. Afterward, rotoevaporation (at 40°C and 27 mm Hg reduced pressure) of the homogeneous liquid obtained was performed for ethanol elimination from it in order to avoid the possible bias of the results of the pharmacological evaluations. The remaining liquid was stored in closed dark bottles at 4 to 8°C until used. The total soluble solids (TSS) content of the extract was gravimetrically determined in dried 1 mL aliquots (three replicates) by using a Sartorius MA40 analytical balance. A mean value of 400 mg/mL was obtained.
Phytochemical Screening A phytochemical screening of TFE was performed by the method described earlier, 13 that consisted of the formation of colored and/or insoluble chemical complexes from the secondary metabolites contained in the plant extract.
Animals
Sprague Dawley rats and Balb/c mice were purchased from the National Center for the Production of Laboratory Animals (Havana, Cuba). The animals were placed into polyurethane cages and housed at controlled environment (23°C and 50-60% relative humidity) with free access to food (AL-YCO ® CMO 1000) and water.
Acute Oral Toxicity TFE acute oral toxicity was evaluated in SD rats (both sexes, 200 ± 20 g b.w.) according to 423 OECD guideline. 
Statistical Analysis
The experimental results were expressed as the mean ± standard deviation (SD) of each group of treatment. Normal distribution of data and homogeneity of variance were assessed by Shapiro-Wilk's and Bartlett´s tests, respectively. The statistical comparison between groups was performed by one-way ANOVA or Kruskal-Wallis test, according to the results of the previous tests. The means were compared by Dunn's and Bonferroni's tests. Differences lower than 5% were considered significant. The GraphPad Prism 5 statistical program was used for this purpose.
Ethics
All procedures described were carried out using a protocol approved by the Institutional Research Ethics Committee of Salvador Allende Faculty of Medicine. The guidelines for good practices for the management of laboratory animals 16,17 were followed.
Results and Discussion
Phytochemical Screening of TFE As can be observed in Table 1 , saponins and phenols - such as: tannins and flavonoids, anthocyanins, alkaloids, quinones, and coumarins -were the major secondary metabolites found in TFE, as previously reported for the flowers and ethanol extracts of T. elatus plants grown in Cuba. 4, 18, 19 This qualitative similarity endorses the contribution of the results of this research for the chemical, pharmacological and toxicological characterization of this botanical species.
Oral Acute Toxicity The demonstration that a research product has a low probability to be toxic for humans is pivotal for the strategy of new drug development. 20 This concept is valid for a plant extract, though it is obtained from parts of those called medicinal plants, since they have complex compositions, as demonstrated for TFE (Table 1) , with the combination of different biological properties that not only could support their medicinal use, but also could result in undesirable bio-logical effects.
The evaluation of acute toxicity in experimental animals is a primary stage of non-clinical estimation of a product's safety. It consists of the evaluation of quantitative and qualitative changes, associated with the administration a single or repeated doses of the substance in a 24-hour period of time. This information offers a basis to calculate the doses of a product for its pharmacological characterization.
In agreement with a previous toxicological study of an ethanol extract of T. elatus flowers, 21 the acute intragastric administration of TFE 2000 mgTSS/kg b.w to rats (a maximal allowable dose 20 ) caused neither deaths nor signs of toxicity among these animals during the 14-day period of observation following the treatment. Also, body weight gain was within the expected limits for this species ( Figure  3) , suggesting that this extract could be safe after a single dose treatment. However, other toxicological studies are necessary to complete the knowledge about this extract safety.
Inhibition of the Increase of Histamine-Induced Capillary Permeability in the Mouse Paw Preliminary experiments for standardization of this experimental model allowed the selection of the doses of histamine and the H1 antihistamine drug ketotifen, to be used in the experiments for the edemagenic stimulus and the positive control respectively. Fifty micrograms of histamine/paw showed to be a proper stimulus level because it produced a measurable, submaximal and reproducible effect. On the other hand, ketotifen 3 mg/kg b.w. had a submaximal inhibitory activity.
Since a single oral dose of TFE 2000 mg/kg showed no toxicity to animals a range of lower doses, being one 1/3 of the other (600; 200 and 67 mg/kg), was selected to assess the extract effect on histamine edemagenic activity in the mouse paw. These numbers approximately correspond to 1/3; 1/9 and 1/27 x 2000 mg/kg respectively. Figure 4 shows that TFE significantly inhibited histamine induced edema at all dose levels tested but not in a dose-independent manner. Consequently, 67 mg/ kg could be the highest effective dose of this extract and its ED 50 could be below it, thus suggesting that it has a favorable security index, higher than 27 after a single oral dose.
Histamine-induced paw edema was significantly lower in the group of mice treated with ketotifen with respect to the negative control group (Figure 4) . The lack of statistical difference between the groups of animals treated with the extract and the one treated with the reference drug ( Figure 4) is a demonstration of similar effectiveness in these experimental conditions that suggests a therapeutic potential of this plant preparation.
The flavonoids contained in TFE could be responsible for the inhibition of histamine effect but it has been said that they do not have antihistamine activity. 22 Consequently, it seems that an unspecific rather than a specific mechanism of action could explain the results. Nevertheless, a contribution of other chemical components to the biological activity of this extract should not be discarded. Additional studies should be aimed to clarify it, and its influence on vascular hyper permeability induced by other stimuli. The results presented here support the hypothesis of this research that an extract of T. elatus flowers could inhibit the edemagenic effect of histamine. Nevertheless, its probable inhibitory effects on the release of histamine, leukotrienes and other inflammatory mediators, as well as on airway contraction and other biological activities associated with the main secondary metabolites present in T. elatus flowers should be evaluated.
Some chronic diseases involving edema and inflammation induced by histamine could also be influenced by this extract. For instance, rutin pharmaceutical products and the micronized purified flavonoid fraction have a demonstrated activity as venotonic agents and are used for the treatment of chronic venous insufficiency. [23] [24] [25] Accordingly, this plant preparation could have a wide [i] field of therapeutic use that deserves further investigation.
Conclusion
The present study has given the first qualitative experimental evidence that a 70% ethanol extract of the dried flower petals of T. elatus plants grown in Cuba contains saponins and phenols such as tannins and flavonoids, anthocyanins, alkaloids, quinones, and coumarins. Also, it did not show acute toxicity in rats. Furthermore, it was able to inhibit histamine-induced paw edema in mice. It was a result of the early stage of a research project that deals with the pharmacological study of this endemic species. 
